<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04997876</url>
  </required_header>
  <id_info>
    <org_study_id>biomarkers</org_study_id>
    <nct_id>NCT04997876</nct_id>
  </id_info>
  <brief_title>Diagnostic Reliability of OCT Biomarkers for iERM</brief_title>
  <official_title>Diagnostic Reliability of OCT Biomarkers for Idiopathic Epiretinal Membranes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vienna Institute for Research in Ocular Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vienna Institute for Research in Ocular Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several optical coherence tomography (OCT) biomarkers with potential to influence&#xD;
      postsurgical outcomes after vitrectomy with membrane peeling for idiopathic epiretinal&#xD;
      membranes (iERM) have been described in single predictor analyses in the past. Aim of the&#xD;
      study is to assess the reliability of diagnosis of OCT biomarkers and to calculate their&#xD;
      impact on postsurgical visual acuity in a multiple regression analysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several optical coherence tomography (OCT) biomarkers with potential to influence&#xD;
      postsurgical outcomes after vitrectomy with membrane peeling for idiopathic epiretinal&#xD;
      membranes (iERM) have been described in single predictor analyses in the past. A recent&#xD;
      multifactorial analysis outlined macular thickness and DRIL to be significant predictors for&#xD;
      postsurgical visual acuity (Karasavviodou et al.). Nevertheless, reliability of diagnosing&#xD;
      OCT biomarkes among patients with iERM was not yet assessed, to our knowledge. Aim of the&#xD;
      study is to assess the reliability of diagnosis of OCT biomarkers and to calculate their&#xD;
      impact on postsurgical visual acuity in a multiple regression analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 11, 2021</start_date>
  <completion_date type="Actual">August 21, 2021</completion_date>
  <primary_completion_date type="Actual">August 5, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>reliability of diagnosing OCT biomarkers</measure>
    <time_frame>1 week</time_frame>
    <description>The presence (yes/no) of following OCT biomarkers are diagnosed from preoperative OCTs: EIFL, DRIL, intraretinal cystoid changes, alterations of the ellipsoid zone, cotton ball sign, HR-foci, EMM-rips, and retinal contraction. Intra- and interobserver reliability is assessed from 2 different readers, and reliability of OCT biomarkers will be calculated with the Kuder Richardson 20 test, due to the dichtomic nature of outcomes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postsurgical best corrected visual acuity</measure>
    <time_frame>3 months</time_frame>
    <description>best corrected visual acuity 3 months after surgery is used for regression analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>central macular thickness</measure>
    <time_frame>5 minutes</time_frame>
    <description>presurgical central subfield thickness of the macula is assessed by the software of the OCT device. The subfield thickness with a diameter of 1mm will be selected.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">136</enrollment>
  <condition>Idiopathic Epiretinal Membranes</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
    <description>Biomarkers from presurgical OCTs are diagnosed</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biomarker analysis</intervention_name>
    <description>Biomarkers from presurgical OCTs are assessed</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with iERM sheduled for vitrectomy with membrane peeling.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  a) presence of an iERM,&#xD;
&#xD;
          -  b) indication for membrane peeling, defined as significant loss of visual acuity&#xD;
             and/or metamorphopsia due to the ERM,&#xD;
&#xD;
          -  c) pseudophakia at the final visit at 3 months after surgery, and&#xD;
&#xD;
          -  d) written informed consent for study participation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  macular edema caused by conditions other than ERM were excluded from the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver Findl, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>head of department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VIROS at Hanusch-Hospital Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Karasavvidou EM, Panos GD, Koronis S, Kozobolis VP, Tranos PG. Optical coherence tomography biomarkers for visual acuity in patients with idiopathic epiretinal membrane. Eur J Ophthalmol. 2020 Dec 14:1120672120980951. doi: 10.1177/1120672120980951. [Epub ahead of print]</citation>
    <PMID>33307784</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 2, 2021</study_first_submitted>
  <study_first_submitted_qc>August 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2021</study_first_posted>
  <last_update_submitted>August 21, 2021</last_update_submitted>
  <last_update_submitted_qc>August 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vienna Institute for Research in Ocular Surgery</investigator_affiliation>
    <investigator_full_name>Prim. Prof. Dr. Oliver Findl, MBA</investigator_full_name>
    <investigator_title>Prof., MD, MBA</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

